###begin article-title 0
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Different Regulation of Atrial ANP Release through Neuropeptide Y2 and Y4 Receptors
###end article-title 0
###begin p 1
###xml 335 336 335 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 496 497 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 630 631 630 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 725 732 725 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1, 2, 5</sub>
###xml 838 839 838 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 998 999 998 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1195 1196 1195 1196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1202 1203 1202 1203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Neuropeptide Y (NPY) receptors are present in cardiac membranes. However, its physiological roles in the heart are not clear. The aim of this study was to define the direct effects of pancreatic polypeptide (PP) on atrial dynamics and atrial natriuretic peptide (ANP) release in perfused beating atria. Pancreatic polypeptides, a NPY Y4 receptor agonist, decreased atrial contractility but was not dose-dependent. The ANP release was stimulated by PP in a dose-dependent manner. GR 23118, a NPY Y4 receptor agonist, also increased the ANP release and the potency was greater than PP. In contrast, peptide YY (3-36) (PYY), an NPY Y2 receptor agonist, suppressed the release of ANP with positive inotropy. NPY, an agonist for Y1, 2, 5 receptor, did not cause any significant changes. The pretreatment of NPY (18-36), an antagonist for NPY Y3 receptor, markedly attenuated the stimulation of ANP release by PP but did not affect the suppression of ANP release by PYY. BIIE0246, an antagonist for NPY Y2 receptor, attenuated the suppression of ANP release by PYY. The responsiveness of atrial contractility to PP or PYY was not affected by either of the antagonists. These results suggest that NPY Y4 and Y2 receptor differently regulate the release of atrial ANP.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 534 535 534 535 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 538 539 538 539 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 542 543 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 546 547 546 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 554 555 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 641 642 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 727 728 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 759 760 759 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 819 820 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 831 832 831 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 878 879 878 879 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 882 883 882 883 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 890 891 890 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
Pancreatic polypeptide (PP) and peptide YY (PYY) belong to the neuropeptide Y (NPY) family, which have well-conserved amino acid sequences (1) containing numerous tyrosines and tertiary structures (2, 3) with wide variation in anatomical distribution (4). The structural similarity between these peptides leads to the hypothesis that they are homologous, belonging to a family that has been termed the NPY family on the basis that NPY is evolutionarily the most ancient member. Five receptors for NPY family have so far been cloned, Y1, Y2, Y4, Y5, and y6, and found to belong to the huge family of heptahelical G protein-coupled receptors (5). Y4 receptor mRNA has been detected in the heart, gut, adrenal gland and artery (6-8). PP has a high affinity for Y4 receptor whereas PYY and NPY have a low affinity for the Y4 receptor (9, 10). PYY is as potent as NPY in activating Y1, Y2, and Y5 receptors.
###end p 3
###begin p 4
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 682 683 682 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 694 695 694 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 727 728 727 728 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 831 832 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 967 968 967 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1007 1008 1007 1008 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 596 599 <span type="species:ncbi:10116">Rat</span>
###xml 705 710 <span type="species:ncbi:10090">mouse</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1392 1395 <span type="species:ncbi:10116">rat</span>
Among these peptides, PP expression is restricted to pancreatic endocrine cells, type F islet cells, in which PP is released into the circulation after ingestion of food to regulate pancreatic and gastric secretion, as well as gallbladder contraction (11). PYY is also expressed in both neurons of gastrointestinal tracts and endocrine cells, where it has an inhibitory effect on gastric motility and secretion (4). NPY is co-localized with noradrenaline in most sympathetic nerve fibers throughout the body (12). Several studies about cardiovascular functions of NPY family have been performed. Rat PP inhibits neurogenic vasoconstriction evoked by electrical stimulation through Y4 receptor (4). In the mouse, NPY activates Y2 receptor on the parasympathetic nerve terminal (13) and evokes potent vasoconstriction by activating Y1 receptors. A recent study (14) showing slow heart rate and low mean arterial pressure as a result of reduced sympathetic activity in Y4 receptor-knockout mice suggests that Y4 receptor deletion disrupts autonomic balance within the cardiovascular system. Only a few reports about the effects of PP on cardiovascular function are available (14, 15). Therefore, the aim of the present study was to investigate the direct effects of PP on atrial dynamics and atrial natriuretic peptide (ANP) release and to identify its receptor subtypes using isolated perfused rat atria.
###end p 4
###begin title 5
MATERIALS AND METHODS
###end title 5
###begin title 6
Animals
###end title 6
###begin p 7
###xml 213 223 213 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 0 19 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
Sprague-Dawley rats, weighing 300-350 g, were obtained from the Orientbio Inc. (Seoungnam, Korea), were housed throughout the experiments in a laminar flow cabinet, and were maintained on standard laboratory chow ad libitum. All experimental animals used in this study were performed under a protocol approved by the Institutional Animal Care and Use Committee of the Chonbuk National University. Standard guidelines for laboratory animal care were followed.
###end p 7
###begin title 8
Experimental procedures
###end title 8
###begin p 9
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 477 478 477 478 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 491 492 491 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 506 507 506 507 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 613 614 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 534 540 <span type="species:ncbi:9913">bovine</span>
Isolated perfused beating atria were prepared using a previously described method (16). In brief, the left atrium was dissected from the heart after killing and fixed into a Tygon cannula. The cannulated atrium was transferred into an organ chamber, immediately perfused with oxygenated HEPES buffer solution at 36.5℃, and paced at 1.3 Hz (duration 0.3 msec, voltage 40 V). The composition of the HEPES buffer solution was as follows (HEPES 10 mM, NaCl 118 mM, KCl 4.7 mM, CaCl2 2.5 mM, MgSO4 1.2 mM, NaHCO3 25 mM, glucose 10 mM, and bovine serum albumin 0.1%, pH 7.4). The pericardial buffer solution contained (3H) inulin to measure the translocation of extracellular fluid (ECF). Intraatrial pressure was recorded on a Physiograph (MK-IV, Narco Bio-systems INC., Houston, TX, U.S.A.) via a pressure transducer (Statham P23Db, Oxnard, CA, U.S.A.) and pulse pressure was calculated from the differences in systolic and diastolic intra-atrial pressures. After stabilization for 100 min, the perfusate was collected at 2-min intervals under 4℃.
###end p 9
###begin p 10
###xml 249 251 249 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-8</sup>
###xml 261 263 261 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 297 298 297 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 473 474 473 474 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 500 501 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 522 524 522 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 550 551 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 572 574 572 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 599 604 599 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,2,5</sub>
###xml 625 627 625 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 585 588 <span type="species:ncbi:10116">rat</span>
Experiments were performed with four groups. Group 1 was atrium perfused with HEPES buffer (n=6) throughout the experiment. After stabilization, the perfusate was collected at 2-min intervals for 70 min. Group 2 was atrium perfused with human PP (10-8M, n=6; 10-7M, n=8; 3x10-7M, n=7). PP, a NPY Y4 receptor agonist, was introduced into the atrial lumen after a 10-min control period, and perfusate was collected for 60 min. Group 3 was atrium perfused with GR 23118 (NPY Y1 receptor antagonist and Y4 receptor agonist, 10-7M, n=6), PYY (3-36) (NPY Y2 receptor agonist, 10-7M, n=7) or rat NPY (NPY Y1,2,5 receptor agonist, 10-7M, n=8). GR 23118, PYY or NPY was introduced into the atrial lumen after a 10-min control period, and perfusate was collected for 60 min.
###end p 10
###begin p 11
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 152 154 152 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 186 187 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 282 284 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
Group 4 was atrium pretreated with an antagonist for Y3 or Y2 receptor. NPY (18-36) (3x10-7M, n=7), an antagonist for NPY Y3 receptor, or BIIE0246 (3x10-7M, n=7), an antagonist for NPY Y2 receptor was administered as a pretreatment at 20 min after the start of the perfusion. PP (10-7 M, n=7) or PYY (3-36) (10-7M, n=7) was simultaneously infused with an inhibitor after a 10-min control period.
###end p 11
###begin title 12
Measurement of ANP concentration
###end title 12
###begin p 13
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 243 248 <span type="species:ncbi:42554">tetra</span>
###xml 269 276 <span type="species:ncbi:3847">soybean</span>
###xml 452 458 <span type="species:ncbi:9913">bovine</span>
The concentrations of immunoreactive ANP in the perfusate were measured with a specific radioimmunoassay (RIA), as described previously (17). RIA was performed in Tris-acetate buffer (0.1 M, pH 7.4) containing neomycin (0.2%), ethylenediamine tetra-acetic acid (1 mM), soybean trypsin inhibitor (50 benzoyl arginine ethyl ester units/mL), aprotinin (200 kallikrein inhibiting unit/mL), phenylmethylsulfonyl fluoride (0.4 mg%), sodium azide (0.02%) and bovine serum albumin (1%). Standard and samples were incubated with anti-ANP antibody and (125I) ANP for 24 hr at 4℃. Bound forms were separated from the free form using a charcoal suspension or second antibody. RIA for ANP was done on the day of experiments and all samples in an experiment were analyzed in a single assay.
###end p 13
###begin p 14
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 524 526 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 528 530 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
We previously reported a two-step sequential mechanism of ANP secretion from the atrium (18, 19): first, atrial release of ANP into the interstitial space occurs by means of atrial stretching, and second, the released ANP is translocated into the atrial lumen, concomitantly with ECF translocation due to contraction. Therefore, the interstitial ANP concentration was calculated using the ANP secretion divided by extracellular fluid (ECF) translocation and 3060 (molecular mass for ANP-[1-28]) and was expressed in microM (18, 19).
###end p 14
###begin title 15
Measurement of ECF translocation
###end title 15
###begin p 16
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
The radioactivity of (3H) inulin in the atrial perfusate was measured with a liquid scintillation counter (Tris-Carb 23-TR; A Packard Bioscience Company, Downers Grove, IL, U.S.A.). The amount of ECF translocated through the atrial wall was calculated from the total radioactivity in the perfusate divided by the radioactivity in the pericardial reservoir and atrial wet weight and was expressed in microL/min/g.
###end p 16
###begin title 17
Statistical analysis
###end title 17
###begin p 18
###xml 222 223 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The results are presented as the means+/-S.E.M. The statistical significance of the differences was assessed using analysis of variance followed by Duncan multiple range test. The critical level of significance was set at p<0.05.
###end p 18
###begin title 19
RESULTS
###end title 19
###begin title 20
Effects of PP on atrial contractility and ANP release
###end title 20
###begin p 21
###xml 161 163 161 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-8</sup>
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 178 180 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 183 190 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1A</xref>
###xml 335 343 335 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1Aa</xref>
###xml 415 423 415 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1Ac</xref>
###xml 490 498 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1Ab</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 871 879 871 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1Ad</xref>
After stabilization for 100 min, the perfusate was collected five times every 2 min to serve as a control period and then PP was infused at a concentration of 10-8, 10-7, or 3x10-7M. Fig. 1A shows the effects of PP on contractility, ECF translocation, ANP secretion, and ANP concentration with time. PP decreased atrial contractility (Fig. 1Aa). The secretion of ANP gradually increased in a dose-dependent manner (Fig. 1Ac) throughout the experiment without a change in ECF translocation (Fig. 1Ab). We have previously reported that the ANP released from atrial myocytes into the interstitial space is translocated into the atrial lumen, concomitantly with ECF translocation (18, 19). The translocation of ECF is dependent on atrial contractility in this model. Therefore, the ANP secretion in terms of ECF translocation, which means the interstitial ANP concentration (Fig. 1Ad), was significantly increased by PP.
###end p 21
###begin p 22
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1B</xref>
###xml 331 339 331 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1Ba</xref>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1Bb</xref>
###xml 478 480 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-8</sup>
###xml 484 486 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 495 497 489 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 543 551 537 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1Bc</xref>
Fig. 1B shows the relative percent changes in pulse pressure, ECF translocation, ANP secretion and concentration obtained from the mean of five control values and the five peak experimental values (50-60 min after drug infusion) for exposure to the different doses of PP. PP decreased atrial contractility without dose-dependency (Fig. 1Ba) but ECF translocation did not change (Fig. 1Bb). The ANP secretion was increased by 16.52+/-7.29, 35.35+/-10.13, and 48.22+/-10.42% by 10-8, 10-7, or 3x10-7M PP, respectively, which was dose-dependent (Fig. 1Bc).
###end p 22
###begin title 23
Effects of GR 23118, PYY (3-36) and NPY on atrial contractility and ANP release
###end title 23
###begin p 24
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 114 119 114 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,2,5</sub>
###xml 139 140 139 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 204 206 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 352 359 352 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2A</xref>
###xml 554 566 554 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2Aa, Ab</xref>
###xml 645 653 645 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2Ac</xref>
To compare the intra-atrial effects of GR 23118 (Y1 antagonist and Y4 agonist), PYY (3-36) (Y2 agonist) and NPY (Y1,2,5 agonist) with PP (Y4 agonist), GR 23118, PYY (3-36) or NPY, at a concentration of 10-7M, was perfused into atrial lumen. GR 23118 caused a gradual increase in ANP release and decreases in atrial contractility and ECF translocation (Fig. 2A). In contrast, PYY (3-36) abruptly decreased the ANP secretion and concentration, which maintained throughout the experiment. Atrial contractility and ECF translocation significantly increased (Fig. 2Aa, Ab). NPY slightly decreased the ANP secretion until 30 min without significance (Fig. 2Ac). Atrial contractility and ECF translocation also did not change significantly.
###end p 24
###begin p 25
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2B</xref>
Fig. 2B shows the comparison of relative percent changes in several parameters by GR 23118, PYY (3-36) and NPY with PP. GR23118-stimulated ANP secretion was greater than PP. The suppression of ANP secretion by NPY and PYY was significantly different from that by PP.
###end p 25
###begin title 26
Modification of intra-atrial effects of PP and PYY (3-36) by receptor antagonists
###end title 26
###begin p 27
###xml 101 102 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 138 139 138 139 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 320 327 320 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3A</xref>
###xml 407 417 407 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3C, D</xref>
###xml 653 654 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
To determine which Y receptor subtype(s) is(are) involved in PP-induced ANP secretion, NPY (18-36), Y3 receptor antagonist, or BIIE0246, Y2 receptor antagonist, was pretreated and PP or PYY (3-36) was simultaneously perfused. PP-induced negative inotropy was not affected by the pretreatment of NPY (18-36) or BIIE0246 (Fig. 3A). However, PP-stimulated ANP secretion was markedly attenuated by NPY (18-36) (Fig. 3C, D) but was not affected by BIIE0246. Both positive inotropy and suppression of ANP secretion by PYY (3-36) were not affected by NPY (18-36). PYY (3-36) -induced suppression of ANP secretion was attenuated by BIIE0246, an antagonist for Y2 receptor.
###end p 27
###begin title 28
DISCUSSION
###end title 28
###begin p 29
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 120 121 120 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In the present study, we found that PP and GR 23118 (Y4 receptor agonists) increased ANP secretion and PYY (3-36) (NPY Y2 agonist) decreased ANP secretion. Therefore, we suggest that NPY receptors differently regulate the release of ANP.
###end p 29
###begin p 30
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 797 798 797 798 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 833 834 833 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 864 865 864 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 871 872 871 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1040 1041 1040 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1052 1054 1052 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1072 1073 1072 1073 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1148 1150 1148 1150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1317 1318 1317 1318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1394 1395 1394 1395 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1401 1402 1401 1402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1495 1496 1495 1496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1529 1530 1529 1530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1619 1620 1619 1620 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1653 1654 1653 1654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1726 1727 1726 1727 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1781 1782 1781 1782 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1857 1858 1857 1858 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1971 1973 1971 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2049 2050 2049 2050 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 2062 2064 2062 2064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 2102 2103 2102 2103 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 2126 2127 2126 2127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 2215 2216 2215 2216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 2222 2223 2222 2223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 144 147 <span type="species:ncbi:10116">rat</span>
###xml 152 157 <span type="species:ncbi:10090">mouse</span>
###xml 610 613 <span type="species:ncbi:10116">rat</span>
###xml 954 957 <span type="species:ncbi:10116">Rat</span>
###xml 1083 1087 <span type="species:ncbi:10090">mice</span>
PP, mainly produced in the gut, retains up to 50% residue identity to NPY or PYY, and a strong similarity in the C-terminal secretion. PP binds rat and mouse Y4 receptor with very high affinity (7, 20), which is expressed in the periphery (21), including adrenal gland, gut, kidney (22) and heart. Although many studies on gastric actions of PP have been reported such as stimulation of gastric emptying, secretion and motility (23), a few report on cardiovascular function of PP are present (14, 15). In the present study, we investigated the intra-atrial direct effects of PP and PYY using isolated perfused rat atria. PP caused an increase in ANP secretion and negative inotropy. In contrast, PYY (3-36) caused a decrease in ANP secretion. It has been reported that PP has a high affinity for Y4 receptor (24) and PYY (3-36) for Y2 receptor (9). In the heart, Y2 and Y4 receptors have been shown to have an important role on cardiovascular functions. Rat PP inhibits neurogenic vasoconstriction evoked by electrical stimulation through Y4 receptor (21) and transgenic Y4-knockout mice show the significant impairment of cardiovascular function (14). We wanted to define which NPY receptor subtypes are involved in the regulation of ANP secretion and atrial contractility by PP and PYY (3-36). However, a specific Y4 receptor antagonist is not available. Therefore, specific antagonists for Y2 and Y3 receptor subtypes were used. The PP-induced stimulation of ANP secretion was attenuated by Y3 receptor antagonist but not by Y2 receptor antagonist. PYY (3-36)-induced suppression of ANP secretion was attenuated by Y2 receptor antagonist but not by Y3 receptor antagonist. These results show a possible involvement of the Y3 receptor for PP-induced ANP secretion. However, the Y3 receptor to this day is unproven, and even scientists who originated the Y3 concept have confirmed negative findings (especially with the CXCR4 chemokine receptor) related to the concept (25). It has also been reported that NPY (18-36) may act as an antagonist for Y4 receptors (26). Additionally, GR23118, a specific Y4 receptor agonist and Y1 antagonist, stimulated the ANF secretion more than PP. Therefore, we suggest that NPY Y2 and Y4 receptors may differently regulate the release of atrial ANP.
###end p 30
###begin p 31
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
In this study, PP caused negative inotropy and PYY (3-36) caused positive inotropy. This response was relatively small. Neither Y2 nor Y3 receptor antagonists modified the inotropic effects of PP and PYY (3-36). It is not clear that the hemodynamic changes by PP and PYY (3-36) are their own effects because of the small change and no observable dose-dependency. Because of the lack of inotropic effects by PP and PYY (3-36), the translocation of ECF was not significantly changed. Therefore, we suggest that PP and PYY (3-36) lack direct atrial inotropic effects.
###end p 31
###begin p 32
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
What is the physiological significance of PP-induced ANP release? It has been reported that following ingestion of food or hypoglycemia, PP is released from pancreatic F islet cells into circulation to regulate pancreatic and gastric secretion. We do not know the blood concentration of PP in hypoglycemic condition. However, it is possible that PP-induced ANP release may partly participate the ANP-dependent lipolysis (27) followed by an increased blood glucose level.
###end p 32
###begin p 33
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
In conclusion, we suggest that NPY Y2 and Y4 receptors differently regulate the release of atrial ANP.
###end p 33
###begin p 34
###xml 32 72 32 72 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korea Science and Engineering Foundation</funding-source>
###xml 74 94 74 94 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01-2006-000-10554-0</award-id>
###xml 107 166 107 166 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korea Health 21 R &amp; D Project, Ministry of Health &amp; Welfare</funding-source>
###xml 168 175 168 175 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A0603F6</award-id>
This study was supported by the Korea Science and Engineering Foundation (R01-2006-000-10554-0) and by the Korea Health 21 R & D Project, Ministry of Health & Welfare (A0603F6).
###end p 34
###begin article-title 35
Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide
###end article-title 35
###begin article-title 36
Molecular structure of mammalian neuropeptide Y: analysis by molecular cloning and computer-aided comparison with crystal structure of avian homologue
###end article-title 36
###begin article-title 37
Analysis of structure-function relationships of neuropeptide Y using molecular dynamics simulations and pharmacological activity and binding measurements
###end article-title 37
###begin article-title 38
Distribution of pancreatic polypeptide and peptide YY
###end article-title 38
###begin article-title 39
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors
###end article-title 39
###begin article-title 40
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 124 127 <span type="species:ncbi:10116">rat</span>
Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon
###end article-title 40
###begin article-title 41
Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family
###end article-title 41
###begin article-title 42
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Localization and characterization of pancreatic polypeptide receptors in rat adrenal glands
###end article-title 42
###begin article-title 43
###xml 39 44 <span type="species:ncbi:9606">human</span>
Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY
###end article-title 43
###begin article-title 44
###xml 44 47 <span type="species:ncbi:10116">rat</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
A structure-activity analysis of the cloned rat and human Y4 receptors for pancreatic polypeptide
###end article-title 44
###begin article-title 45
Vagal control of digestion: Modulation by central neural and peripheral endocrine factors
###end article-title 45
###begin article-title 46
###xml 95 98 <span type="species:ncbi:9606">man</span>
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man
###end article-title 46
###begin article-title 47
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Cardiac function in neuropeptide Y Y4 receptor-knockout mice
###end article-title 47
###begin article-title 48
Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission
###end article-title 48
###begin article-title 49
Neuromodulation of the cardiac vagus: comparison of neuropeptide Y and related peptides
###end article-title 49
###begin article-title 50
Decreases in ANP secretion by lysophosphatidylcholine through protein kinase C
###end article-title 50
###begin article-title 51
###xml 104 110 <span type="species:ncbi:9986">rabbit</span>
Reduction volume dependence of immunoreactive atrial natriuretic peptide secretion in isolated perfused rabbit atria
###end article-title 51
###begin article-title 52
###xml 82 88 <span type="species:ncbi:9986">rabbit</span>
Sequential mechanism of atrial natriuretic peptide secretion in isolated perfused rabbit atria
###end article-title 52
###begin article-title 53
###xml 46 52 <span type="species:ncbi:9986">rabbit</span>
Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion
###end article-title 53
###begin article-title 54
###xml 11 14 <span type="species:ncbi:10116">rat</span>
The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor
###end article-title 54
###begin article-title 55
###xml 58 61 <span type="species:ncbi:10116">rat</span>
Evidence of a specific pancreatic polypeptide receptor in rat arterial smooth muscle
###end article-title 55
###begin article-title 56
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 25 26 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 83 89 <span type="species:ncbi:9986">rabbit</span>
Characterization of Y1, Y2 and Y5 subtypes of the neuropeptide Y (NPY) receptor in rabbit kidney. Sensitivity of ligand binding to guanine nucleotides and phospholipase C inhibitors
###end article-title 56
###begin article-title 57
###xml 90 94 <span type="species:ncbi:10116">rats</span>
Pancreatic polypeptide stimulates gastric motility through a vagal-dependent mechanism in rats
###end article-title 57
###begin article-title 58
###xml 52 57 <span type="species:ncbi:9606">human</span>
###xml 62 65 <span type="species:ncbi:10116">rat</span>
Cloning and functional expression of cDNAs encoding human and rat pancreatic polypeptide receptors
###end article-title 58
###begin article-title 59
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 116 117 116 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors
###end article-title 59
###begin article-title 60
Pancreatic polypeptide receptors: affinity, sodium sensitivity and stability of agonist binding
###end article-title 60
###begin article-title 61
###xml 106 111 <span type="species:ncbi:9606">human</span>
Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells
###end article-title 61
###begin p 62
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 41 43 41 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-8</sup>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 358 359 358 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 900 901 900 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 901 902 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 909 915 909 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 915 916 910 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 181 184 <span type="species:ncbi:10116">rat</span>
(A) Effects of pancreatic polypeptide (10-8M, n=6; 10-7M, n=8; 3x10-7M, n=7) on pulse pressure, ECF translocation, ANP secretion, and ANP concentration in isolated perfused beating rat atria. Pancreatic polypeptide decreased atrial contractility without change in ECF translocation. The ANP secretion and concentration gradually increased in terms of time. (B) Relative percent changes in pulse pressure, ECF translocation, ANP secretion, and ANP concentration by pancreatic polypeptide. Values were expressed as percent changes of the five peak experimental values for exposure to pancreatic polypeptide, as compared to the mean of the five control values. Pancreatic polypeptide increased the ANP secretion in a dose-dependent manner. Arrow indicates the start time of peptide infusion. PP, pancreatic polypeptide; CONT, control group; ECF transloc, ECF translocation; ANP conc, ANP concentration. *p<0.05; daggerp<0.01 vs. corresponding dose.
###end p 62
###begin p 63
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 68 70 68 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 143 145 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 647 648 647 648 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1134 1140 1134 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 1142 1143 1142 1143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1143 1144 1143 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1151 1157 1151 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 1157 1158 1152 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 257 260 <span type="species:ncbi:10116">rat</span>
(A) Effects of pancreatic polypeptide (PP, 10-7M, n=8), GR 23118 (10-7M, n=6), neuropeptide Y (NPY, 10-7M, n=8), and peptide YY (3-36) (PYY, 10-7M, n=7) on pulse pressure, ECF translocation, ANP secretion, and ANP concentration in isolated perfused beating rat atria. GR 23118 decreased atrial contractility and ECF translocation, and increased the ANP secretion. In contrast, peptide YY (3-36) increased atrial contractility and ECF translocation. The ANP secretion and concentration gradually decreased in terms of time. Neuropeptide Y also decreased the ANP secretion without significant changes in atrial contractility and ECF translocation. (B) Comparison of relative percent changes in several parameters between GR 23118, neuropeptide, peptide YY (3-36) and pancreatic polypeptide. Values were expressed as percent changes of the three peak experimental values for exposure to neuropeptide family, as compared to mean of the five control values. There was a significant difference in changes in ANP secretion by GR 23118, neuropeptide Y, and peptide YY (3-36), as compared to pancreatic polypeptide. Legends are the same as in Fig. 1. *p<0.05; daggerp<0.01 vs. pancreatic polypeptide-exposed group.
###end p 63
###begin p 64
###xml 58 59 58 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 81 82 81 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 100 101 100 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 127 128 127 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 163 165 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 270 272 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 298 300 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 498 504 498 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 506 507 506 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 515 521 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 521 522 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Comparison of relative percent changes in pulse pressure (A), ECF translocation (B), ANP secretion (C), and ANP concentration (D) by pancreatic polypeptide (PP, 10-7M, n=7) and peptide YY (3-36) (PYY, 10-7M, n=7) in the presence and absence of neuropeptide (18-36) (3x10-7M, n=7) and BIIE0246 (3x10-7M, n=7). Pancreatic polypeptide-stimulated ANP secretion was attenuated by neuropeptide (18-36) and peptide YY (3-36)-suppressed ANP secretion was attenuated by BIIE0246. Legends are the same as in Fig. 1. *p<0.05; daggerp<0.01 vs. the control group.
###end p 64

